Neervannan Seshadri

Tarsus Pharmaceuticals, Inc. · Chief Operating Officer

Neervannan Seshadri is listed in filings as Chief Operating Officer at Tarsus Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Mar 24, 2026, including sale activity. Recent filings connect the profile to Tarsus Pharmaceuticals, Inc. (TARS). The current snapshot covers public activity from Mar 7, 2025 to Mar 24, 2026. Reported amounts are shown as $199.5K to $248.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Latest Trades

CompanyValueActionPriceLast Price
Tarsus Pharmaceuticals, Inc.TARS$200k3k sharesSellMar 20, 2026$66.75$57.69